PSG_210745 - Draft Guidance on Apremilast
FDA-2007-D-0369-2535Other
Comments
0
Awaiting comments
Deadline
6 days
Closes Jul 22, 2026
Net supportiSupport minus oppose · campaigns included
—
Document
Details
The document's own metadata, straight from the source system.
- Title
- PSG_210745 - Draft Guidance on Apremilast
- Posted
- May 22, 2026
- Comment period
- May 22, 2026 – Jul 22, 2026
Analysis
Overview
No comments yet — comment period closing soon · 6 days left.
Comments
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
Filter:
No comments match.